Faculty of Medicine

What's New in Research Funding

Molecular structuresPage last updated July 18, 2019

We are pleased to assist the research community in identifying potential sources of funding through the provision of information posted here:

  • All Applicants submitting through the University of Toronto MUST have submitted their application information online via the My Research Applications (MRA) portal. This is an online submission process to obtain institutional approval on research applications. Please note that you will be required to upload a copy of the application to this online submission. Please complete this step as early as possible and at least several days ahead of the deadline to insure all approvals are obtained on time. Please visit the OVPRI's MRA webpage for complete information on this process.
  • Please note, all grants requiring the Dean's signature should be brought to the Faculty of Medicine Research Office in the Medical Sciences Building, Room 2331 to the attention of Cindy Faber cindy.faber@utoronto.ca.
  • Also, our office offers a grant editing service for researchers submitting proposals to tri-council or any other funding agency. For more information, please contact dan.harney@utoronto.ca.
  • Recently received news and updates are posted below and sent via email to our LISTSERV. To join click here.

Comprehensive funding opportunities may be searched through these links:

Recently Received News and Updates

July 18, 2019

  • New Frontiers in Research Fund (NFRF) - Exploration 2019 - UofT Tips and Checklist now available. All competition documents are available on the NFRF website and the Convergence Portal is open.
    The University of Toronto’s Research Services Office has now prepared an NOI Tips and Checklist document, available on the UofT funding opportunity listing, that applicants may use as an additional resource to those available from NFRF. If your primary affiliation is at one of the affiliated hospitals you should apply through that institution as your Administering Organization. You will not be able to change your Administering Organization from the NOI to the LOI (and then to the Full Application) stage so it is important to apply with the correct affiliation now. It is the responsibility of the Nominated Principal Investigator to ensure that each team member is eligible and that the team’s composition meets all of the program’s eligibility guidelines. 
    UoT internal deadline: August 1, 2019.

  • University of Toronto - July 29 Launch: New online submission process for Material Transfer Agreements, Confidential Disclosure Agreements, and other non-funded research agreements. On Monday, July 29th, 2019, the process for initiating the following types of non-funded research agreements will change:
    •    Material Transfer Agreement (MTA)
    •    Confidential Disclosure Agreement (CDA)
    •    Data Transfer Agreement (DTA)
    •    Research Memorandum of Understanding (MOU)
    •    Research Equipment Loan Agreement
    •    Visiting Scientist IP Agreement
    •    Non-Funded Research Collaboration Agreement
    The Division of the Vice President, Research & Innovation (VPRI) in partnership with the Office of the Chief Information Officer (CIO) are expanding the My Research Applications (MRA) service to allow researchers to electronically submit requests for non-funded research agreements via the web portal to the Innovations & Partnerships Office (IPO) for institutional approvals and processing. Visit here to see the benefits of this expanded service, resources, contact information and other information.
  • CIHR Project Grants: Fall 2019 Competition - Learning for Applicants and upcoming webinars. CIHR just launched the Project Grant: Fall 2019 Competition and related Priority Announcements. The Learning for Applicants page has been updated with materials to support applicants through the Registration and Application stages of the competition. Specifically, these learning materials include:
    •    Modules: Project Grant modules are listed on the Learning for Applicants page and provide an overview of the competition as well as a detailed tour of the application process, including requirements such as completing the Equity and Diversity Questionnaire
    •    Webinars: Spaces are still available in the Project Grant: Fall 2019 Question and Answer webinars, which will run until August 28th. All attendees are asked to review the presentation, reference materials and applicant learning modules in advance of the webinar to ensure that everyone’s experience is as productive as possible.
  • The Kidney Foundation of Canada: Kidney Health Research Grants (formerly Biomedical Research Grants). The Kidney Foundation of Canada is pleased to announce that the value of this grant has increased to $120,000 over two years with a maximum of $60,000 per year. The Kidney Health Research Grant competition has moved to an on-line application system. All forms, policies and procedures can be found on the proposalCENTRAL website. Deadline for Letters of Intent: September 1, 2019; Full applications due: October 1, 2019.
  • Cancer Research Institute (CRI): Irvington Postdoctoral Fellowship Program. This program supports qualified young scientists at leading universities and research centers around the world who wish to receive training in fundamental immunology or cancer immunology. Fellowships provide a stipend of $55,000 for the first year, $57,000 for the second year, and $59,000 for the third year. Sponsor deadline: October 1, 2019.
  • NIH Various Opportunities. Visit here to see the National Institutes of Health's recently released requests for applications and program announcements. For more information on NIH application and the submission process, please visit the University's Research Funding Opportunities found here.
  • National MS Society.
    • Pilot Research Grants. The grants are awarded for one year for research conducted by scientists and clinicians that focus on unique or novel ideas with the potential to open significant new areas of research on multiple sclerosis. The maximum budget is USD $50,000 in direct costs. Deadline for applications: September 11, 2019.
    • Research GrantsThe grants are awarded to multi-year research conducted by scientists and clinicians involving basic, clinical and rehabilitation research for a period of 1 to 5 years. Deadline for applications: August 7, 2019.
  • Simons Foundation Autism Research Initiative (SFARI): Winter 2020 Pilot Grants. SFARI is now accepting applications that address areas relevant to improving the scientific understanding, diagnosis and treatment of autism spectrum disorders. These areas include genetics and other factors contributing to risk; molecular and cellular mechanisms; synaptic and circuit physiology; sensory perception; cognition; behaviour; and clinical and translational studies. The Pilot Award supports innovative, high-impact, proposals requesting support for small-scale projects or early-stage experiments that build on preliminary data.  The maximum budget is USD $300,000 (including 20% indirect costs) for up to 2 years. Deadline for submissions: September 13, 2019.
  • Meso Foundation: Grants for Mesothelioma Research. The Meso Foundation (formerly known as MARF) is a nonprofit dedicated to ending the suffering caused by mesothelioma. They are the international collaboration of patients and families, physicians, advocates, and researchers dedicated to eradicating the life-ending and vicious effects of mesothelioma. Amount: Up to USD $50,000 per year for up to two years. Deadline for Letters of Intent: August 26, 2019; Full applications due: January 8, 2020.
  • American Foundation for Suicide Prevention (AFSP): Linked Standard Research Innovation Grants. All AFSP research grants are designed to support research on suicide from a variety of disciplines including psychiatry, medicine, psychology, genetics, epidemiology, neurobiology, sociology, nursing, health services administration, social work, and many others. Grants are not intended to support the development or implementation of prevention programs, educational programs, treatments, or other interventions that do not have a significant research component. Amount: Up to USD $300,000 for up to two years. Deadline for Letters of Intent: September 15, 2019; Full applications due: November 15, 2019.
  • Scleroderma Foundation: Established Investigator Award. The Scleroderma Foundation seeks applications from promising established investigators both inside and outside the field of scleroderma research who wish to propose pilot studies to obtain preliminary data dealing with a highly innovative and/or highly relevant theme related to the disease. This grant will support pilot research that is likely to lead to more substantial unlimited research project grants from federal or non-federal sources. Amount: Up to USD $150,000 for up to two years. Deadline for applications: September 16, 2019.

July 4, 2019

  • New Frontiers in Research Fund (NFRF) - Exploration 2019. All competition documents are available on the NFRF website and the Convergence Portal is open. The objective of this competition is to generate opportunities for researchers at all career stages to conduct high-risk, high-reward and interdisciplinary research not available through funding opportunities currently offered by the three agencies. It seeks to inspire highly innovative projects that defy current research paradigms, propose a unique scientific direction, bring disciplines together beyond the traditional disciplinary approaches, and/or use different perspectives to solve existing problems. Amount: Up to $125,000 per year over 1 or 2 years (includes $25,000/year indirect costs). Projects must include elements from at least two different disciplines (as defined by a group-level classification based on the Canadian Research and Development Classification). Projects must meaningfully engage members of underrepresented groups within the research team, and are expected to integrate sex and gender in their research designs, when appropriate. For full details on project requirements, please see the funding opportunity description. NOI deadline: August 7, 2019; LOI deadline: September 4, 2019; Application deadline: December 10, 2019. Information of UofT applicants can be found here.

    NFRF- Explorations 2019 NOI Webinars: NFRF will be hosting webinars for applicants and research administrators at each stage.  There is a limit of 1000 attendees per webinar so participants are encouraged to join webinars as a group.  Links to the webinar will publicly available approximately one hour prior to the start time. Webinars will be recorded and presentations available following the session.
    English - July 9 from 1pm-3pm or July 17 from 10am-12pm
    French - July 10 from 10am-12pm or July 15 from 1pm-3pm
  • NSERC Chairs for Women in Science and Engineering Program. The call is open to the Ontario and Prairies regions. The aim of this program is to increase the participation and retention of women in science and engineering, while also providing role modes for women that are in, and considering, careers in these fields. The CWSE Program is regional—with one Chair for each of the Atlantic, Quebec, Ontario, Prairies, and British Columbia/Yukon regions. Details about this program and how to apply can be found here. Internal deadline for nominations: September 4, 2019; Sponsor deadline: October 8, 2019.
  • Stem Cell Network: Research Funding Programs. Deadline for full applications for all programs: August 8, 2019.
    • Translation and Society Program supports ethical, legal and social implications projects that focus on impediments in the translation of innovative stem cell research. Amount: Up to $75,000 over 25 months.
    • Fueling Biotechnology Partnerships Program supports academic partnerships with emerging Canadian regenerative medicine biotech companies, who are working to drive an innovative stem cell based technology or therapy into the clinic or market. Amount: Up to $500,000 over 25 years.
    • The Accelerating Clinical Translation Program supports multi-disciplinary research projects focused on stem cell-related technologies or cell therapies expected to reach clinical trials activity within five years. This
      program will also support translational research activities (including Ethical Legal and Social Implications (ELSI) questions) associated with an ongoing clinical trial that will enable the trials next phase of activity. Projects principally focused on basic research are not eligible for funding. Amount: Up to $600,000 over 25 months. 
    • The Advancing Clinical Trials Program supports projects that focus on novel cellular or stem cell-related therapeutic approaches to tissue repair and regeneration for specific diseases. Eligible clinical trials must be testing Canadian innovations at the Phase I or II stage, have received both Research Ethics Board (REB) and Clinical Trials Approval (CTA) from Health Canada, and are not duplicative of other research taking place globally. Amount: Up to $1,000,000 over 25 months.
  • Cancer Research Institute (CRI): Clinic and Laboratory Integration Program (CLIP). CRI offers CLIP grants to qualified scientists who are working to explore clinically relevant questions aimed at improving the effectiveness of cancer immunotherapies. The grant will support basic, pre-clinical, and translational research that will provide information that can be directly applied to optimizing cancer immunotherapy in the clinic. In partnership with the Chordoma Foundation, CRI has secured designated funding that will provide for additional CLIP grants focused on topics related to accelerating the development of effective treatments and ultimately a cure for chordoma. Amount: $200,000 over two years. Deadline for LOIs: November 1, 2019; Invited application deadline: February 15, 2020.
  • Burroughs Wellcome fund: Investigators in the Pathogenesis of Infectious Disease. The objective of this funding opportunity is to support accomplished investigators, at the assistant professor level, to study pathogenesis with a focus on 1) the interplay between human and microbial biology, and 2) the fundamentals that affect the outcomes of these encounters: how colonization, infection, commensalism and other relationships play out at levels ranging from molecular interactions to systemic ones. Amount: Up to USD $500,000 over 5 years. Deadline for pre-proposals: July 15, 2019.
  • Leukemia & Lymphoma Society (LLS): Specialized Center of Research (SCOR) Program. The SCOR grant program is intended to bring together established investigators from one or several institutions to develop a focused research program, foster new interactions and cooperation, and enhance interdisciplinary research among the participants. The overall goal of this mechanism is to enhance the development of innovative strategies for the treatment, diagnosis or prevention of hematological malignancies. Strategies that move discoveries from the bench to the clinic are of high importance as are integrated translational projects. A major focus is translatability to the clinic within the time frame of the SCOR, or shortly after the grant term ends. Amount: Up to $5,000,000 over five years including indirect costs. Deadline for Letters of Intent: August 31, 2019.
  • Susan G. Komen: Career Catalyst Research Grants. The objective of the Career Catalyst Research Grant is to 1) support early career breast cancer researchers, 2) bridge the funding gap faced by faculty as they start their careers in breast cancer research, and 3) prepare early researchers to compete for future independent funding. The grant provides support for hypothesis-driven research projects. The topic area for the FY20 Career Catalyst Research Award is Redefining Metastatic Breast Cancer through Liquid Biopsy.  Amount: USD $150,000 per year for three years including indirect costs. Registration deadline: July 10, 2019: Deadline for Letters of Intent: July 29, 2019.
  • National Eczema Association: Research Grants. Deadline for applications: August 30 at 5pm PDT.
    • Engagement Research Grant: Small research grants for emerging investigators intended to explore a new research concept, pilot a new experiment or undertake a novel or secondary data analysis. Amount: Up to USD $5,000 for each project.
    • Catalyst Research Grant: Designed to support talented early-career scientists on the path toward becoming the next generation of eczema thought leaders by supporting hypothesis-driven research projects. Amount: Up to USD $50,000 for each project.
    • Eczema Champion Research Grant: Encourages proven researchers to continue research on emerging or ongoing challenges in eczema or bring their expertise to the field of eczema. Amount: Up to USD $100,000 for each project.
  • National Multiple Sclerosis Society: Pilot Research Grants. The objective of these grants is to provide funds for limited, short term support of research in areas where preliminary data are scant or nonexistent. The program is designed to support new, unique or novel ideas with the potential to open significant new areas of research on multiple sclerosis. Amount: Up to USD $50,000 for one year in direct costs. Deadline for pre-applications: September 9, 2019.

June 28, 2019

  • University of Toronto: 2020 President's Impact Awards. These annual awards celebrate and honour faculty members whose research has led to significant impact beyond academia. President’s Impact Award winners receive a monetary award of $10,000 per year for five years to be used toward their research, and are also designated by the University as members of the President’s Impact Academy for a minimum of five years. Nominations should be led by a Chair, Academic Director, Vice- or Associate Dean Research, or Vice-Principal Research as appropriate, and must be endorsed by the nominee’s academic division. The deadline for nominations is Thursday, October 31, 2019. Please check with divisional awards offices for earlier internal deadlines. Nominees whose research impact is related to public policy may be simultaneously nominated for the Carolyn Tuohy Impact on Public Policy Award, a separate award that is presented annually under the banner of the U of T Awards of Excellence. Visit here for eligibility and other criteria.
  • CIHR Pre-Announcement: Methamphetamine and Related Psychostimulant Use Operating Grants. The use of methamphetamines and other psychostimulants is increasing but there is a relative lack of high-quality data on the scale of the issue, and its impacts on healthcare and the health service system. This funding opportunity is designed to lay the groundwork for successful interventions at all levels – including treatment, harm reduction, and at the levels of health service systems and health care policies. Amount: Up to $100,000 over one years. Launch: July 2019; Registration deadline: August 2019; Deadline: September 2019.
  • New Frontiers Research Fund - Transformation: Pre-Release Framework and ConsultationThe Canada Research Coordinating Committee (CRCC) released the Transformation Stream program framework, and invites the community to provide feedback on the framework in advance of an anticipated program launch in October 2019. The Transformation stream is designed to support large-scale, Canadian-led interdisciplinary research projects that address a major challenge with the potential to realize real and lasting change (high reward). The challenge may be fundamental, leading to a scientific breakthrough, or applied, with a social, economic, environmental or health impact. Projects are expected to be world-leading, drawing on global research expertise, where relevant. Up to 6 awards of $24M ($4M per year), including direct costs, may be awarded. Stakeholders are invited to provide feedback, comments, suggestions and questions on the Framework to CRCC by August 1, 2019. The University of Toronto will be coordinating an institutional response.  You are welcome to send us your comments for inclusion in the institutional response, please email NFRF.Transformation@utoronto.ca before July 29, 2019.  Alternatively, you may send feedback directly to the CRCC by email at NFRF-FNFR@chairs-chaires.gc.ca and kindly copy NFRF.Transformation@utoronto.ca
  • Canada-UK Artificial Intelligence Initiative. This initiative is an interdisciplinary joint call aimed at building competitive, resilient and healthy economies and societies through responsible AI. The call aims to support innovative and cutting-edge interdisciplinary AI research that encourages the exploration of new interdisciplinary research methodologies, approaches and tools that cuts across at least two of the following research domains:
    •    social sciences and humanities;
    •    health and biomedical sciences; and 
    •    natural sciences and engineering (including computational and/or mathematical sciences).
    The total amount available for this funding opportunity is about C$14 million (£8.2 million), enough to fund up to approximately 10 projects. Canadian applicants are only eligible to receive funding from the Canadian agencies and UK applicants are only eligible to receive funding from UKRI. Each grant will require a Principal Investigator (PI) based in Canada and a PI based in the UK from different research domains, who will jointly develop one application and equally share leadership and project management for each project. Further details here. WEBINAR for potential applicants: July 17, 2019.
    Compulsory Intention to Submit: August 19, 2019.
  • Biocodex Microbiota Foundation - Microbiome in human health and diseases. Biocodex Microbiota Foundation is calling on inspired researchers at Canadian institutions in the microbiome field to submit proposals for funding their projects. This Canadian grant of 25,000 €.will be awarded to an early career investigator studying a 1 - 2 year long research project within the topic of microbiome in human health and diseases. The grant is intended as a seeding or bridging grant, to help investigators become independent or advance in the progression of their career. Holders of CIHR Foundation grants or total funding exceeding 200k per year may not apply. Deadline for applications: October 31, 2019.
  • Immunodeficiency Canada: Chaim Roifman Scholar Award for Senior Investigators. Each fall, Immunodeficiency Canada requests proposals focused on research in primary immune deficiency (PI). Research objectives should address one or more of the unique needs of patients with primary immunodeficiency: 
    - Study the clinical, cellular and molecular characteristics of genetically determined immunodeficiency diseases 
    - Discover improved diagnostic tools for PI 
    - Advance novel therapeutic approaches for PI 
    - Advance education of patients and medical professionals
    Amount: Up to $60,000. Deadline for Letters of Intent: September 27, 2019; Application deadline: November 29, 2019.
  • American Association for Cancer Research (AACR): Stand Up to Cancer Gastric Cancer Interception Research Team.  This Team Grant represents a new, focused effort to implement advances in gastric cancer interception and prevention research as rapidly as possible through the creation of a collaborative, translational, cancer "Research Team". The most talented and promising researchers across institutions will be assembled into a Research Team, forming an optimal configuration of expertise needed to solve key problems in gastric cancer interception and prevention research. This Research Team will span multiple disciplines within and beyond the gastric oncology community, ideally including investigators with expertise outside the biological sciences, and utilize new tools to answer research questions in a coordinated way. One grant of up to USD $3 million will be awarded. Deadline for Expressions of Interest: July 30, 2019; Application deadline: August 20, 2019. 
  • American Association for Cancer Research (AACR): AACR-Johnson & Johnson Lung Cancer Innovation Science Grants. These grants represent a joint effort to address the need for promoting and supporting collaborative cancer research in areas that include digital therapeutics and smoking cessation biomarkers/behavioral phenotyping, to bolster our understanding of how lung cancer can be successfully intercepted. This project must be implemented by a multi-institutional team, composed of Principal Investigators from at least two, but no more than three, different institutions and include a clinical component with an endpoint relevant to improving the detection or treatment of lung cancer. Amount: Up to USD $1 million over three years. Deadline for applications: July 19, 2019.
  • Leukemia & Lymphoma Society (LLS): Translational Research Program (TRP). Applications are sought proposing novel approaches to the prevention, diagnosis or treatment of hematological malignancies and related pre-malignant conditions. Proposals should be based on molecular, cellular or integrated systems findings and be conceptually innovative. The application should have a clear plan for the clinical translation of the studies proposed and the results expected. This feature will be an important consideration of the review process. Amount: USD $650,000 over two years. Deadline for Letters of Intent: August 31, 2019; Application deadline: October 31, 2019.
  • Benign Essential Blepharospasm Research Foundation, Inc. (BEBRF): Request for Blepharospasm/Meige Research ProposalsFunds are available for support of research directly related to the cause of, treatment for, and complications derived from treatments for benign essential blepharospasm or Meige's Syndrome, both forms of cranial dystonia. Proposals for improvement of existing treatments and for new treatments (such as medical marijuana and neuroplasticity training for blepharospasm) are welcome. Novel therapies for apraxia of eyelid opening, dry eye, and photophobia will also be considered for funding. Amount: Up to USD $100,000 for one year. Deadline for applications: August 31, 2019.
  • American Gastroenterological Association (AGA): Rome Foundation Functional GI and Motility Disorders Pilot Research Award. The objective of this AGA Research Foundation award is to provide investigators funds to help establish their research careers or support pilot projects that represent new research directions. The intent of the award is to stimulate research in the areas of functional GI and motility disorders by providing time for investigators to obtain new data that can ultimately lead to subsequent grant applications for more substantial funding and duration. Two, one year, USD $30,000 research grants are offered. Deadline for applications: September 4, 2019.
  • Alzheimer's Research UK (ARUK): Dementia Consortium - Target validation and drug discovery projects funding. Projects should provide evidence linking the target to human disease and a strong rationale for target modulation having a therapeutic effect. Target validation studies consisting of preclinical research that aims to give confidence in the relevance of a novel target to a disease are supported. Approaches can cover all aspects of dementia therapy, from treating the underlying pathology to improving cognition and other mental symptoms. Targets must be early stage, but should have some data to support their role in disease. Projects are collaborative in nature, with involvement from the consortium members in devising the final project plan. Upper amount: GBP £500,000. Registration deadline: Continuous. 
  • Action for A-T: Research Grants. A wide range of research applications will be considered for funding but Action for A-T has a particular interest in cancer and the respiratory manifestations in A-T. Applications are considered for high quality biological science or translational research projects that may lead to treatments and cures for A-T from applicants in the UK and worldwide. UK based projects will be prioritised for funding. Action for A-T also retains flexible funding so that it can jointly fund research with others during the year and is able to respond quickly to important emerging information and techniques. Amount: Up to GBP £250,000 lasting up to three years. Deadline for applications: September 23, 2019.


June 19, 2019

  • Cystic Fibrosis Canada: 2019 Fall Research Competition.  Cystic Fibrosis Canada’s fall research competition is designed to support leading research into the understanding, management and treatment of, and cure for, cystic fibrosis (CF). All applications must address Cystic Fibrosis Canada’s Core Principles of funding the best science that has the highest probability of making an impact for CF patients. Both Basic Science grants and Clinical Research grants are available. Amount. Up to $100,000 per year for 3 years. Budgets above this amount will be accepted in there is a funding partner. Deadline for Notices of Intent: July 31, 2019 at 5pm. Final application deadline: October 1, 2019.
  • NIH Various Opportunities. Visit here to see the National Institutes of Health's recently released requests for applications and program announcementsFor more information on NIH application and the submission process, please visit the University's Research Funding Opportunities found here.
  • American Foundation for Suicide Prevention: Focus Grants - Blue Sky Research Grant. Supports an innovative, impactful study in an area of suicide research that will achieve significant goals. The goal of this grant is creating innovative projects in new areas of investigation with potentially high impact for the understanding and prevention of suicide. Open to all fields of inquiry. Amount: Up to USD $500,000 per year for up to three years. Deadline for Letters of Intent: August 1, 2019; Application deadline: December 7, 2019.
  • Boston University: CARB-X. CARB-X is investing up to $550 million in antibacterial R&D between 2016-2021. CARB-X welcomes applications from around the world for funding and support for the early development of antibiotics, diagnostics, vaccines and other products to combat the most serious drug-resistant bacteria. There are four separate CARB-X Funding Rounds in 2019:
    • Vaccines and Biotherapeutics: The scope of Round 2 is restricted to vaccines, therapeutic and preventative antibodies/fragments, and other large molecule biotherapeutic approaches. Deadline for EOIs: July 15, 2019.
    • Diagnostics: The scope of Round 3 is restricted to diagnostics that will rapidly identify either the bacterial species or antibiotic susceptibility, or both. Deadline EOIs: August 19, 2019.
    • Direct-acting small molecule antibiotics: The scope of Round 4 is restricted to new classes of antibiotics and/or new targets for therapeutics. Deadline for EOIs: November 19, 2019.
    • Non-traditional approaches: The scope of Round 2 is restricted to non-traditional approaches - alternatives to antibiotics - including, for example, indirect-acting small molecule therapeutics, direct acting or indirect-acting large molecules, microbiome, phage, nucleic acid/antisense, and drug conjugates. Anticpated deadline for EOIs: June 10, 2020.
  • Global Lyme Alliance (GLA): Research Grant Award Program. GLA has awarded more than $10 million in grants to scientists at more than 40 academic institutions to study Lyme and other tick-borne diseases. Proposals are expected to be of high scientific quality from scientists and clinicians who use evidence-based, data-driven research to drive knowledge forward. Research priorities include Lyme Disease and Babesiosis. Projects are expected to be completed in one to two years. Deadline for Letters of Intent: July 22, 2019.
  • Wings for Life (WFL) Spinal Cord Research Foundation: Project Research Grant. Research projects may address all aspects of spinal cord lesions; nerve regeneration; trophic support of lesioned neurons; functional changes induced by lesions; and preferentially in mammalian models. Proposals should have a view to translation from the laboratory to the clinical setting, and have the potential to provide real benefits to human patients. Amount: Up to EUR €100,000 per year all inclusive. Deadline for executive summary: September 2, 2019; Application deadline: November 2, 2019. 
  • Wellcome Trust: Impact of vaccines on antimicrobial resistance (NEW). This supports researchers investigating the impact of vaccines on antibiotic use and antimicrobial resistance with the aim of informing vaccine decision-makers around the world and tackling antimicrobial resistance. Projects must aim to analyse data on antimicrobial resistance or antibiotic use in the context of a vaccine study. They may analyse existing data or collect and analyse new data from an ongoing or planned vaccine study. Data may include antibiotic use, drug-resistant infections, antibiotic prescribing behaviour and antibiotic seeking behaviour. Amount: Up to GBP £750,000 and the duration of the programme is flexible and dependent on the level of funding. Deadline for preliminary proposals: September 6, 2019; Full proposals due September 12, 2019.
  • Mizutani Foundation for Glycoscience: Research Grants. The objective of the Foundation is to promote world-wide progress in glycoscience. In accordance with this objective, the Foundation provides research grants to outstanding proposals for basic and applied studies on glycoconjugate in the fields of organic chemistry, biochemistry, biophysics, molecular biology, cellular biology and medical sciences. Amount: Up to JPY ¥7,000,000 (approximately USD $58,000). Deadline for applications: September 1, 2019. 

June 13, 2019

  • Entrepreneurship for Cardiovascular Health Opportunities (ECHO) – Call for Applications The Translational Biology & Engineering Program (TBEP), at the University of Toronto and the Ted Rogers Centre for Heart Research, in partnership with the Health Innovation Hub (H2i) is pleased to announce a call for applications for the 2019-2020 Entrepreneurship for Cardiovascular Health Opportunities (ECHO) program.
     ECHO is a specialized experiential training program with the main objectives to:
    1.    Provide entrepreneurship training, mentorship, networking and funding opportunities for early ventures in the cardiovascular health sector.
    2.    Aid in transferring research innovations and intellectual property from academic and hospital institutions into the economy.
    3.    Create more start-ups in cardiovascular health sector.
    Any Canadian-based student, researcher and/or entrepreneur developing advanced cardiovascular technologies and innovations is eligible to apply. For full program information and enrolment instructions, please visit the ECHO program page. Deadline for submissions: August 1, 2019.
  • 2019 NSERC Discovery Grant NOI Information Session. Hosted by UofT. Topics covered in the session include the Notice of Intent, program requirements, eligibility requirements, changes for this year’s competition (Research Portal and Canadian Common CV), evaluation criteria and proposal development. Guest speaker: Professor Christopher Yip, Dean, Faculty of Applied Science & Engineering. For details on the submission and approval process, including internal deadlines, required signatures and information sessions, please see the Research Services webpage, as well as the NSERC Discovery Grants webpage. For those who are unable to attend this session in person, they have set up a Skype for Business link so that you can participate in the session remotely. Details here.
    DATE: July 9, 2019 from 1pm - 3pm
    LOCATION: Bahen Centre, BA 1200, 40 St. George St. Please RSVP to Teresa.Trimboli@utoronto.ca.
  • The Ministry of Economic Development, Job Creation and Trade (MEDJCT): Early Researcher Award (ERA) - Round 15. The ERA program helps promising, recently-appointed Ontario researchers build their research teams of undergraduates, graduate students, post-doctoral fellows, research assistants, associates, and technicians. The ERA program will provide funding up to $100,000 for each award (plus $40,000 for indirect costs), and must be matched by an additional $50,000 (generally from the division/department and/or a partner organization). Further details on the program including program guidelines and the application form can be found on the research funding opportunity page
    INFORMATION SESSION: July 25 from 10am - 12pm
    LOCATION: Bahen Centre, BA 1200, 40 St. George St. Please RSVP to renee.leroux@utoronto.ca. Please note that attendance of this session is limited to PIs and their support staff who will be submitting their applications through UofT.
  • SEEDing Innovation: First Annual XSeed and EMHSeed Poster Session. This event is an excellent opportunity to learn about the broad range of collaborative research projects funded by our seed funding programs and to identify potential future collaborations. Attendance is open to all faculty members. For planning purposes, RSVP to vdr@ecf.utoronto.ca by June 21. In addition, if you do not have a XSeed or EMHSeed project but plan on applying to the upcoming XSeed or EMHSeed competitions, we encourage you to consider presenting a poster at this event. 
    Date: Thursday, June 27, 2019 from 1pm - 3pm
    Location: Myhal Centre for Entrepreneurship & Innovation in Engineering5th Floor Atrium (MY532), 55 St. George Street

  • Brain Tumour Charity. These awards are open to international researchers but all proposals must demonstrate how they can benefit patients in the UK health system. Deadline proposals: September 2, 2019.
    • Clinical Biomarkers support the identification, validation, and implementation of clinical biomarkers that bring us closer to an early and accurate diagnosis, and/or inform the management of brain tumours. These grants are available for up to £100,000 per year for up to five years.
    • Quality of Life Awards provide funding to increase understanding and minimise the impact of brain tumours on those affected. Funding is up to £300,000 per project for up to three years. 
    • Expanding Theories Awards support pilot studies that explore and develop novel concepts that may eventually lead to significant improvements in clinical outcomes, including quality of life, for people with brain tumours. Applications including a UK collaborator will be looked on favourably. Funding of up to £60,000 per year, for up to two years can be requested.

June 6, 2019

  • REMINDER! CIHR's new Strategic Plan: Invitation for public engagement. CIHR is inviting the health research community to visit https://letstalk-cihr.ca/ its new online engagement platform to take a survey, join the discussion forum, or leave a question with respect to its new strategic plan. The online survey will be open until June 28, 2019.
  • NSERC: Idea to Innovation (I2I) Program - Commercialization Grants. The purpose of this program is to accelerate pre-competitive technologies for transfer to a Canadian company. Successful applicants receive awards of up to $125,000 for each phase of their commercialization project, with additional funding available as the project progresses. All projects must be based on inventions disclosed and assigned to the University, and should be managed in conjunction with the Innovations & Partnerships Office (IPO) – the Innovations team in particular can assist with development of the Commercialization Plan, and can also assist in determining the appropriate Phase for your project. UofT internal deadline: Monday, June 17, 2019 (upload and submit the application through the university's My Research Application (MRA) System); Sponsor deadline: June 25, 2019. Questions may be directed to innovations.partnerships@utoronto.ca or visit NSERC's website.
  • The Ministry of Economic Development, Job Creation, and Trade (MEDJCT): Ontario Research Fund - Research Excellence Round 10 (ORF-RE). The ORF-RE program provides funding to support the operational costs of major projects of strategic value to the province. This program provides up to one third of the total value of a project, with the remaining two thirds coming from private sector partners and institutional contributions. ORF-RE Round 10 has two application funding tiers: Tier 1 funds projects from $200,000 to $1,000,000. Open to all disciplines; Tier 2 funds projects from $1,000,001 to $4,000,000. Open to all disciplines. Further details, program guidelines and the application form will be available shortly.  Visit here for further details and timelines.
    INFORMATION SESSION: June 18, 2019 from 10am - 12pm in the Medical Sciences Building, Room 2173, 1 King's College Circle. RSVP to renee.leroux@utoronto.ca
    BUDGET INFORMATION SESSION: July 23, 2019 from 10am - 12pm in the Medical Sciences Building, Room 2173, 1 King's College Circle. RSVP to renee.leroux@utoronto.ca
  • Symposium - UofT Talks: Destination Health: Unpacking the Migrant Experience. This year's talk will be an evening of discourse on the barriers that migrants face in Canada when trying to access healthcare. As Canada accepts more and more refugees, it’s becoming increasingly important that we understand how this influx of people will impact an already stressed system. figure out how we can create supports to ensure that everyone that needs healthcare has access to it. Full agenda here.
    Date: June 20, 2019 from 6pm - 9pm at the Innis Town Hall Theatre, 2 Sussex Ave., Toronto
    Tickets@uofttalks.ca $15.00 general admission; $10 Student
  • CIHR and Muscular Dystrophy Canada (MDC): Network Catalyst Grants. This funding opportunity will provide support for the creation of six networks. The aim of these networks will be to provide research leadership in its focus area, to foster innovative research and practices, to build capacity and provide a forum that engages the research community and its partners (including but not limited to industry, charities, and patients and their carers). This opportunity will provide funding for networks in the priority research areas of the funding partners. For CIHR-IMHA and MDC, these areas include Musculoskeletal (MSK) Rehabilitation, Muscular Dystrophy and Skin Health. For CIHR-INMHA, these networks seek to catalyze new research areas within the Institute's mandate. Registration deadline: July 9, 2019; Full application deadline: August 8, 2019.
  • Lung Cancer Canada: Geoff Ogram Memorial Research Grant. This grant supports advancement in lung cancer research programs that are anywhere in the continuum from basic, high impact discovery to translational work of direct relevance to the clinic and beyond. The goal of the GOMRF program is to provide a mechanism for scientists to study innovations and accelerate the application of new knowledge relating to the early detection of lung cancer and the etiology of lung cancer in different demographics and populations. Applications are encouraged from, but not limited to, the areas of biomedical, clinical, health services, social, and population health research. One $25,000 grant will be awarded. The application form can be found hereDeadline for applications: June 28, 2019.
  • Simons Foundation Autism Research Initiative (SFARI): Bridge to Independence (BTI) Award. The BTI Award program promotes talented early-career scientists by facilitating their transition to research independence and providing grant funding at the start of their professorships. Annual Request for applications (RFA) open each spring and are aimed at senior postdoctoral fellows who intend to seek tenure-track faculty positions during the upcoming academic year. Awardees will receive a commitment of $495,000 over three years, activated upon assumption of a tenure-track professorship at a U.S. or Canadian research institution. Importantly, although eligible applicants must be currently in a postdoctoral training position, the BTI Award itself is not a training fellowship but a research grant to newly appointed faculty. Deadline for Letters of Intent and Letters of Recommendation: August 8, 2019.
  • Alex's Lemonade Stand Foundation.
    • 2019 Psychosocial Launch Grants are designed for early career researchers within 7 years of receiving their terminal degree/completing formal training. Funding will support studies that aim to explain and/or improve psychosocial outcomes of those affected by childhood cancer. Demonstration of outstanding mentorship and a career plan that shows commitment to pediatric cancer investigation are important components of a successful application. Maximum USD $50,000 per year for two years. Deadline for Letters of Intent: June 17, 2019.
    • 2019 Psychosocial Family Impact Grant is designed for established investigators. Funding will support studies that aim to explain and/or improve psychosocial outcomes of those affected by childhood cancer. This grant is designed to fund researchers who have novel approaches to understanding the psychosocial aspects of pediatric cancer and whose proposals will have clinically significant impact. Amount: Up to USD $100,000 per year for 3 years. Deadline for Letters of Intent: June 17, 2019.
  • Solving Kid's Cancer (SKC): Therapeutic Development Initiative (TDI) - Funding for High-Impact Pediatric Cancer Research. The TDI of SKC only supports clinical research. The organization specifically focuses on novel clinical studies for neuroblastoma, brain tumors and sarcomas. TDI Awards are funded in a range from USD $50,000 to USD $600,000 depending on the nature of the proposed project. No institutional overhead or indirect funding will be provided. Deadline for preliminary proposals: Continuous.
  • American Society of Clinical Oncology: Global Oncology Young Investigator Award (GO YIA). The GO YIA provides research funding to early-career investigators to encourage and promote quality research in global oncology and to develop the next generation researchers to address global health needs. "Global oncology" is a term that generally refers to the application of the concepts of global health to cancer, and implies an approach to the practice of oncology that acknowledges the reality of limited resources in most parts of the world. Amount: Up to USD $50,000 for one year. Deadline for applications: June 27, 2019.
  • National Organization for Rare Diseases (NORD): Rare Disease Research Grant Program. NORD’s Rare Disease Research Grant Program is accepting proposals for the study of the following eight rare diseases. All U.S. and international researchers interested in studying one or more of these diseases are encouraged to apply by Tuesday, June 18, 2019.
    • Alveolar Capillary Dysplasia with Misalignment of the Pulmonary Veins (ACD/MPV) – One grant of up to USD $50,000
    • Appendix Cancer and Pseudomyxoma Peritonei (PMP) – Two grants of up to a combined total of USD $100,000
    • Autoimmune Polyglandular Syndrome Type 1 (APS-1) – One grant of up to USD $100,000
    • Biliary Atresia – Two grants of up to a combined total of USD $190,500
    • Malonic Aciduria- One grant of up to USD $52,000
    • Neuroendocrine Cell Hyperplasia of Infancy (NEHI) – One grant of up to USD $30,000
    • New-Onset Refractory Status Epilepticus (NORSE) and Febrile Infection-Related Epilepsy Syndrome (FIRES) – Two grants of up to a combined total of USD $100,000
    • Primary Orthostatic Tremor – One grant of up to $42,500  
  • JDRF: Strategic Research Agreements - Multi-Project SRA. The JDRF SRA for multiple projects provides a mechanism to stimulate new collaborations between clinical and basic scientists and/or between scientists from diverse backgrounds as a means to conceive and develop new approaches to major challenges, potential breakthroughs, or persistent obstacles to progress along the various paths to prevent, treat or cure Type 1 diabetes and its complications. Available funding for the Strategic Research Agreement will be reviewed on a per-application basis. Deadline for concept papers/proposals: August 1, 2019; November 4, 2019; or February 3, 2020.
  • John Templeton Foundation: Small & Large Grants. Core Funding Areas: 1. Science & the Big Questions (Mathematical & Physical Sciences; Human Sciences; Philosophy & Theology); Public Engagement); 2. Character Virtue Development; 3. Individual Freedom & Free Markets; 4. Exceptional Cognitive Talent & Genius; 5. Genetics; and 6. Voluntary Family Planning. Individual grants range greatly in amount, from several thousand dollars to several million. Small Grants: USD $234,800 or less. Large Grants: more than USD $234,800. Grant duration is normally up to three years. Deadline for Letters of Inquiry/preliminary inquiry: August 16, 2019; Deadline for full proposals: January 17, 2020.
  • Epilepsy Foundation: New Therapy Commercialization Grant and Epilepsy Seal of Innovation Award. The Program seeks to advance the development of new therapies including but not limited to medicines, biologics or devices. All proposals must demonstrate a clear path from the lab to the patient and are evaluated with consideration for their potential value to patients, likelihood of successful development including regulatory approval and the timeframe of development. The Program also encourages 1:1 matching grants to academic and commercial entities to support the commercialization of novel approaches to the treatment of epilepsy. Amount: New Commercialization Grant - Up to USD $350,000 for up to two years; Epilepsy Seal of Innovation Award - Up to USD $200,000 for one year. Deadline for Letters of Intent: June 21, 2019 or January 28, 2020.
  • A-T Children's Project. Research Grant Program. Their greatest interest is in funding translational and clinical research projects, particularly those projects focused on the neurological problems faced by all patients with A-T. Amount: Up to USD $150,000 for up to two years. Deadline for Letters of Intent: August 1, 2019; Full application due: September 1, 2019.
  • Restless Legs Syndrome (RLS) Foundation: Research Grants. The RLS Foundation Research Grant Program supports basic and clinical restless legs syndrome (RLS) research. The Foundation challenges the research community to generate novel ideas to unlock the mysteries that will ultimately lead to a cure for this often devastating disease. Amount: USD $35,000 for one year. Deadline for proposals: Continuous.

May 31, 2019

  • NSERC's New "Alliance" Grant: INFORMATION SESSION. Presented by NSERC and hosted  by UofT's Innovations & Partnerships Office. NSERC is currently launching the new “Alliance” Grant – the Research Partnerships Program consolidating and replacing the previous suite of programs including Engage, Collaborative Research and Development (CRD), Industrial Research Chair (IRC), Strategic Partnerships programs (SPG-P and SPG-N), among others.  NSERC is currently accepting applications for large Alliance proposals only (in excess of $150K/yr NSERC support), and will shortly expand intake to include applications for lesser amounts, analogous to the majority of the previous programs.  All applications will be accepted on a rolling basis after the rollout is complete - there will be no application deadlines under Alliance. NSERC personnel will be presenting details of the Alliance program at an information session on the downtown St. George campus on the afternoon of June 26.  PIs and other interested members of the UofT community are welcome to attend.
    DATE: Wednesday, June 26 2019 at 1:30pm
    LOCATION: Bahen Centre (40 St. George), Rm 1170
  • The Centre for Aging + Brain Health Innovation (CABHI): Spark Program. CABHI is inviting point-of-care staff to accelerate their ideas into innovations that can improve the lives of older adults, persons with dementia and their care partners. The Spark program provides up to $50,000 (CAD) in project funding over 12 months that can be used to develop and refine early stage solutions or to adapt and test a commercially available solution in a seniors' care environment. Deadline for applications: July 5, 2019.
  • CIHR Collaborative Health Research Program (CHRP): Applicant WEBINAR. CIHR will be hosting the following webinar to support participants with the requirements of the funding opportunity “Operating Grant: Collaborative Health Research Projects (NSERC Partnered) (2019-2020)” and to answer questions on how to apply. 
    DATE: Monday, June 3, 2019 at 1:00pm ET
    Register here.
  • PRE-ANNOUNCEMENT: CIHR UK-Canada Diabetes Research Team Grants. The objective of this funding opportunity is to accelerate diabetes research into mechanisms and translational solutions to improve the lives of people with diabetes in Canada and the UK through research funding for internationally competitive and innovative UK-Canada Diabetes Research Teams that will enable the pursuit of shared research interests. The focus of the collaborative projects will be upon ‘mechanisms and translational solutions’. This is meant to focus on research applicable to UK and Canadian settings, not on global health. Launch: June 2019.
  • CIHR in partnership with Health Canada: SGBA+ Health Policy-Research Partnerships. In response to the Canadian government's renewed commitment to gender equality, in 2017 Health Canada approved a department-wide Sex and Gender Action Plan. A key activity within this action plan is a partnership between the CIHR Institute of Gender and Health (IGH), and Health Canada’s Gender and Health Unit (GHU). The aim of this collaboration is to fund Policy-Research Partnerships, which will help bridge the gaps between research knowledge and policy development, and support the rigorous application of SGBA+ to ensure Health Canada's outward facing activities address the diverse needs of women, men, girls, boys and gender-diverse people to maximize positive health outcomes and improve the health of Canadians. Research Areas: Applying a SGBA+ lens to prescription drug lifecycle management; and Applying a SGBA+ lens to medical device lifecycle management. Deadline for applications: September 10, 2019.
  • CIHR in partnership with the Terry Fox Research Institute: Terry Fox New Investigator Awards. This program will support outstanding New Investigators to collaborate, and be mentored by, one or more senior investigators of a currently funded research team. Specifically, the research teams are: Terry Fox New Frontiers Program Project; TFRI Translational Program; CIHR Cancer Control Partnerships in Health Services Improvement (PHSI) Grants; CIHR Stand Up to Cancer (SU2C) Canada Dream Teams; and CIHR Large Scale Applied Research Cancer Projects (LSARP).  The maximum amount per grant is $150,000 per year for up to 3 years for a total of $450,000. Deadline for applications: September 13, 2019.
  • The Ministry of Economic Development, Job Creation, and Trade (MEDJCT): Ontario Research Fund - Research Excellence Round 10 (ORF-RE). The ORF-RE program provides funding to support the operational costs of major projects of strategic value to the province. This program provides up to one third of the total value of a project, with the remaining two thirds coming from private sector partners and institutional contributions. ORF-RE Round 10 has two application funding tiers: Tier 1 funds projects from $200,000 to $1,000,000. Open to all disciplines; Tier 2 funds projects from $1,000,001 to $4,000,000. Open to all disciplines. Further details, program guidelines and the application form will be available shortly. An information session will be held in mid-June, details to follow. Visit here for further details and timelines.
  • American Thoracic Society: ATS Foundation Partner Grants - ATS Foundation/Hermansky-Pudlak Syndrome Network Research Grant. The focus of this research grant is proposals that have a high likelihood to advance the understanding of Hermansky-Pudlak Syndrome-associated lung disease. One grant of up to USD $80,000 over two years is available. Deadline for Letters of Intent: June 17, 2019; Full proposals due September 20, 2019.
  • Amgen Inc. Competitive Grant Program in Bone Research. The program aims to improve quality of osteoporosis care and patient outcomes, related to osteoporosis screening, diagnosis, and adherence to therapy. Visit here for specific predefined areas of research eligible for a Competitive Grant Program in Bone Research award. Amount: Up to USD $150,000. Deadline for applications: June 28, 2019.
  • Alzheimer's Drug Discovery Foundation (ADDF): Accelerating Drug Discovery for Frontotemporal Degeneration. The ADDF and The Association for Frontotemporal Degeneration (AFTD) seek to accelerate and support innovative small molecule and biologic (antibodies, oligonucleotides, peptides, gene therapy) drug discovery programs for FTD through this request for proposals. Average Award $100,000 - $150,000. Deadline for Letters of Intent: July 12, 2019; Full proposals due: August 10, 2019.
  • Alzheimer's Research UK (ARUK): Target Validation Pathfinder Grant.  The Target Validation Pathfinder grant scheme (TVPG) is designed to support translational research that shows potential for an application to the Dementia Consortium or collaboration with the ARUK Drug Discovery Alliance, but would benefit from funding for preliminary, early-stage target validation work or feasibility studies to establish the viability of an approach. Amount: Up to GBP  £50,000 for one year. Deadline for applications: July 3, 2019 or November 1, 2019.
  • Kennedy's Disease Association: KDA Research Grants. The Kennedy's Disease Association (KDA) is planning to fund one or more research grants this fall to further the understanding of the pathological mechanisms of Kennedy's Disease. Applications from junior investigators and from senior post-doctoral fellows are encouraged. For independent investigators, grants will be funding up to USD $75,000. For postdoctoral fellows/senior trainees, grants will be funding for up to USD $50,000. Deadline for proposals: July 13, 2019.
  • Histiocytosis Association: Request for Proposals. Proposals for scientific research are accepted for studies into the causes, mechanisms, and improved means of treatment for histiocytic disorders. Proposals are evaluated on the basis of science, feasibility, and relevance. All proposals are expected to address one or more of the histiocytic disorders. Amount: Up to USD $50,000 for one year. Deadline for proposals: July 1, 2019.
  • USAID: Innovations in Malaria Vaccine Development (IMV). USAID is seeking to enhance our malaria vaccine investments through a collaborative design process. The goal of USAID's MVDP is to demonstrate the proof of concept of a vaccine to reduce morbidity and mortality due to malaria caused by infection with Plasmodium falciparum. Target malaria vaccine end characteristics will include at least 75% efficacy and evidence of affordability. USAID intends to support efforts towards vaccines that have the potential to directly protect recipients against disease caused by P. falciparum such as vaccines that target the pre-erythrocytic (sporozoite and liver stage) and erythrocytic stages of the life cycle. Deadline for applications: June 21, 2019.


May 16, 2019

  • REMINDER! 2019 Annual Faculty of Medicine Grant Writing Workshop.  Grad students, post-docs and faculty members in UofT’s health science community are welcome to register and attend the workshop. Join us to learn more about:
    •   Key Services offered by the Office of the Vice Dean, Research & Innovation
    •   Core Facilities & Services available through the Faculty of Medicine
    Natasha Christie-Holmes, PhD, Research Operations Officer, Faculty of Medicine 
    •   A reviewer’s perspective on grant review panels and grant success
    Professor Brenda Andrews, PhD, Director, Donnelly Centre 
    •   Persuasive grant writing tips and techniques
    Daniel Harney, PhD, Grants & Awards Editor, Faculty of Medicine
    DATE: Tuesday, June 4th from 9am - 12pm
    LOCATION: Medical Sciences Building, Room 3153, 1 King's College Circle, Toronto 
    Free to attend. Register here.
  • Inaugural Toronto Cannabis and Cannabinoid Research Consortium (TC3) Research and Networking Symposium. The research symposium will bring together cannabis and cannabinoid researchers and trainees from the University of Toronto and Toronto Academic Health Sciences Network and will provide an opportunity to network, seek new collaborations, build links and share health research findings related to cannabis and cannabinoids. Featuring short talks/data blitzes, panel sessions, and poster presentations, the research day will serve as an interactive platform to highlight preclinical, clinical and policy research in Toronto.
    Registration is complementary for faculty and trainees from the University of Toronto and Toronto Academic Health Sciences Network. The cost for all other attendees is $99. 
    DATE: June 3, 2019 from 8:00am-5:00pm
    LOCATION: Chestnut Conference Centre, 89 Chestnut Street, Toronto
  • 2019 CIHR/NSERC Collaborative Health Research Projects (CHRP). The CHRP Initiative supports innovative, interdisciplinary, collaborative research projects, requiring participation from the natural sciences or engineering community together with the health sciences community. The initiative requires the translation of the research results to knowledge/technology users and related stakeholders outside the academic or training environment. As such, the proposed research projects must have a strong focus on knowledge translation (KT) and lead to health and economic benefits for Canadians through more effective health services and products and/or a strengthened health care system. Applicants from the UofT affiliated hospitals must apply through their University faculty appointment. There is no maximum budget request and the duration is up to three years. Deadline for Letters of Intent: June 25, 2019.
  • CIHR/AZ Canada/CLA Emerging Clinician Scientist Awards. The goal of the award is to support Emerging Clinician Scientists within the first five (5) years of their first faculty appointment in the establishment of their careers. Priority areas include basic and translational research programs in chronic respiratory disease, including but not limited to chronic obstructive pulmonary disease, asthma, cough, chronic bronchitis, bronchiectasis, cystic fibrosis, Bronchopulmonary Dysplasia, Alpha-1 Antitrypsin Deficiency, Interstitial Lung Disease, and Idiopathic Pulmonary Fibrosis. Amount: $100,000 per year for up to 2 years. Registration deadline: June 26, 2019; Application deadline: July 31, 2019.
  • CIHR/CAAIF/AZ Canada/AllerGen Emerging Researcher Awards in Allergic Asthma. The goal of this funding opportunity is to support Canadian Allergists, Clinical Immunologists, MD clinician scientists and basic scientists working in translational research to pursue academic research in allergic asthma. All research proposals received must be relevant to the area of allergic asthma. Amount: $100,000 per year for up to 2 years. Deadline for applications: August 16, 2019.
  • INFORMATION SESSION: SSHRC Partnerships Suite Programs. Research Services will hold an information session about the SSHRC Partnership Engage Grants, Partnership Development Grants and Partnership Grants programs. Professor Shelley Stagg-Peterson, a selection committee member, will discuss the adjudication process and the elements of a strong proposal. There will also be advice on proposal planning and development from members of the Research Services team. RSVP by May 30th to steven.hermans@utoronto.ca.
    DATE: May 31, 2019 from 10:30am-12:00pm.
    Governing Council Chamber, Simcoe Hall, 27 King's College Circle.
  • Nominations invited for Steacie Prize 2019. The Steacie Prize is an award of $10,000 presented once a year to a scientist or engineer of 40 years of age or less for outstanding scientific research carried out in Canada. Nominations should be made by a colleague and sent by e-mail. Details on how to apply can be found here. Please inform dan.harney@utoronto.ca of any submitted nominations within the Faculty of Medicine. Deadline for nominations: June 30, 2019.
  • Mitacs Elevate: Postdoc Funding - Call for Applications. Elevate fellows progress through the program in a cohort, giving them cross-disciplinary networking and peer-learning opportunities they might not have otherwise in their careers. Over the two-year fellowship, Elevate fellows divide their time between their partner organization project and university-based research with their faculty supervisor. Elevates fellows receive $55,000 minimum annual stipend/salary, training curriculum valued at $7,500 per year, submission assistance, and a certificate of completion. UofT Internal deadline: July 10, 2019; Sponsor deadline: July 17, 2019 at 1pm PDT.
  • Eczema Society of Canada: Research Grant Program.  This program allows Canadian researchers, including clinicians, medical students, and fellows, the opportunity to apply for funding for eczema research and/or educational projects that work to improve the lives of Canadians living with eczema. Up to two grants will be awarded in 2019 with a maximum value of $25,000 per grant. Deadline for applications: September 1, 2019.
  • Pfizer, Inc.: Requests for Proposals.
    • 2019 Global Hemophilia 2019  ASPIRE.  Projects that will be considered for Pfizer support will focus on the following areas in Gene Therapy for Hemophilia A or B:  Basic Science of TFPI & Anti-TFPI Monoclonal Antibodies; Patients with MILD Hemophilia A or B. Amount: Up to USD $125,000/year for 1 to 2 years. Pfizer anticipates awarding up to 2 grants.  Deadline for proposals: August 31, 2019.
    • Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research Competitive Grant Program for Junior Investigators. Projects that will be considered for Pfizer support will further improve the understanding of the epidemiology, basic science and early diagnosis and treatment of ATTR-CM through research focused in the following areas: Epidemiologic evaluations for ATTR-CM; Approaches for the early identification and follow up of ATTR-CM patients: • Evaluation of patients with ATTR-CM presenting with a mixed phenotype; Mechanistic studies to advance the basic science of amyloid formation and deposition on the heart; Characteristics of ATTR-CM in post-organ transplant patients, including natural course of disease progression. Amount: Up to USD $75,000 per project. Pfizer anticipates awarding 4 to 5 grants. Deadline for proposals: June 15, 2019. 
  • Lung Cancer Research Foundation: LCRF Pilot Grant Program. This pilot grant program provides funding for research focused on the prevention, diagnosis, treatment and cure of lung cancer. The goal of the program is to fund innovative projects across the spectrum of basic, translational, and clinical research. Amount: Up to USD $75,000 per year for two years. Deadline for applications: June 14, 2019.
  • International Olympic Committee (IOC): Medical and Scientific Research Fund. The IOC has committed to fund selected research pertaining to injury and illness prevention. The IOC Medical and Scientific Commission is calling on researchers to apply for support and funding of athlete-centered projects. Multi-center and collaborative projects and research that has the potential to directly benefit Olympic athletes are encouraged. Areas of research eligible for support include injury and illness prevention studies, as well as IOC Consensus Statement topics, such as transgender athletes and mental health. Amount: Up to USD $100,000. Deadline for applications: June 1, 2019. 


May 9, 2019

  • CIHR's new Strategic Plan: Invitation for public engagement. CIHR is inviting the health research community to visit https://letstalk-cihr.ca/ its new online engagement platform to take a survey, join the discussion forum, or leave a question with respect to its new strategic plan. The online survey will be open until June 28, 2019.
  • INFORMATION SESSION - CGEn: Making whole Genome Sequencing accessible to all Canadian Researchers. 
    Hosted by the Faculty of Medicine and the Innovations & Partnerships Office.
    CGEn is a federally funded national platform for genome sequencing and analysis with centres in Montreal, Toronto and Vancouver. Their mission is to enable Canadian science through the characterization of genome sequences, promote genome research in Canada and build and operate an unprecedented infrastructure that enhances our national capacity for sequencing and analysis. Visit here to see topics and who should attend.
    DATE: Tuesday, May 29, 2019 from 2:30 - 3:30pm
    LOCATION: Donnelly Centre, Black Room (260) 
    Please RSVP to s.brijbassi@utoronto.ca if you are planning to attend.
  • Vector Faculty Affiliates Program 2019. The Vector Institute, based in Toronto, is one of the world’s top destinations for cutting edge research at the intersection of machine-learning, deep learning and reinforcement learning, and they would like Faculty to consider joining them as a Vector Faculty Affiliate. The Vector Faculty Affiliates Program is intended to expand their research community’s expertise in the areas of AI, computer science, engineering, and other disciplines related to machine learning, as well as strategic domains of application. Vector Faculty Affiliates are appointed to a renewable two-year term and form an integral part of the Vector community, engaged in their research and community engagements with part-time access to resources. Where their interests align, Faculty Affiliates can also benefit from interacting with industry sponsors, as well as health and academic partners, through participation in networking events, seminar, training sessions and workshops. Questions should be directed to Jackie.Zuborg@Vectorinstitute.ai, Manager of Research Programs. Deadline for applications: June 6, 2019.
  • CSS/CIHR Cancer Survivorship Team Grant. The goal of this Team Grant program is to improve the health outcomes for cancer survivors of all ages (pediatric, adolescent, young adult and adult) from the time of their cancer diagnosis until the time of their death or entry into palliative care. This program is not intended to focus on improving end-of-life care.  The program goal will be achieved through the support of a network of multidisciplinary teams. The intent of this funding opportunity is to support new intervention research designed to mitigate the challenges experienced along the survivorship journey, as well as the evaluation and validation of existing interventions to assess their potential for implementation as best practices. Registration Deadline: May 29, 2019; Full application deadline: September 10, 2019. 
  • Arthritis Society/CIHR: New/Mid Investigator: Stars Career Development Award. This salary and research funding represents a three (3) year commitment by IMHA and the Arthritis Society, together with an additional three (3) year commitment by the applicant’s Host Institution. The program is intended to promote creativity in all domains of arthritis-related research responsive to the Arthritis Society’s two strategic priorities: Theme 1) Improving our understanding of arthritis and finding the cure; Theme 2) Improving the care and management of arthritis. As part of this program, the applicants Host Institution will be required to commit an additional three (3) years of equivalent research and salary support to the applicant (at an appropriate rank and salary) for a total commitment of six (6) years of support. This funding opportunity will support projects relevant to the following research areas: Improving our understanding of arthritis and finding the cure; and Improving the care and management of arthritis. Further information can in ResearchNet. Abstract registration deadline: May 22, 2019; Full application deadline: June 26, 2019.
  • CMA Foundation: 2019 Healthy Canadians Grants Program. This year’s theme is youth mental health and substance use. This program is designed to provide support for community-run initiatives that improve the quality of life for patients and vulnerable populations living in those communities, thereby having a positive impact on the entire community. With these grants, we’re aiming to make a tangible difference in the lives of youth, their families and the physicians who care for them. Grants will be available for organizations across Canada that are delivering programming at the community level and are focused on improving mental health, reducing and preventing substance use, increasing resiliency, reducing stigma and decreasing barriers to mental health. 15 grants of $20,000 are available. Deadline for applications: May 31, 2019.
  • AGE-WELL Graduate Student and Postdoctoral Awards in Technology and Aging. These awards provide partial funding to highly qualified master’s, doctoral and postdoctoral candidates and provide them with access to training and mentorship opportunities through the AGE-WELL Network of Centres of Excellence. AGE-WELL aims to provide a unique training environment that exposes trainees to multi-disciplinary research environments and to its industry and community partners. AGE-WELL is committed to attracting, developing, and retaining outstanding Highly Qualified Personnel (HQP) in Canada. Further information can be found here. UofT internal deadline for MRAs: May 24, 2019; External deadline: May 31, 2019.
  • Friedreich's Ataxia Research Alliance (FARA): 
    • Bronya J. Keats Award for International Collaboration in Research on FA. Proposals should focus on FA research that relies on international collaboration among investigators in at least two different countries. Special consideration will be given to proposals that bring new scientists to the FA community. The rationale for the collaboration needs to be convincing and must clearly demonstrate that the research goals could not be achieved by just one of the participating groups and that the synergy among the groups is essential for the success of the project. Amount: Up to USD $200,000 per year for 1 or 2 years. Deadline for Letters of Intent: May 15, 2019; Application deadline: July 15, 2019.
    • Kyle Bryant Translational Research Award. This award is given to proposals focused on pre-clinical and clinical investigations that will advance treatments for FA. Amount: Up to USD $250,000 per year for 1 or 2 years. Deadline for Letters of Intent: May 15, 2019; Application deadline: July 15, 2019.
  • Wellcome Trust: Innovator Awards. These awards support researchers who are transforming great ideas into healthcare innovations that could have a significant impact on human health. The Wellcome Trust's current focus areas are: Mental health; neurological disorders; and neglected tropical diseases. Any potential applicants whose proposal doesn't address a problem in one of these areas must provide the Wellcome Trust with information; they will consider whether to extend permission to apply. Funding of up to  £500,000, or up to £750,000 for multidisciplinary collaborations. The duration of funding is usually up to 24 months, or up to 36 months for multidisciplinary collaborations. Deadline for proposals: Continuous.
  • National Rosacea Society: Research Grants. Because the etiology of rosacea is unknown, high priority is given to research in such areas as the pathogenesis, progression, mechanism of action, cell biology and potential genetic factors of this conspicuous and often life-disruptive condition. Studies may also be funded in such areas as epidemiology, predisposition, quality of life and associations with environmental and lifestyle factors. Amount: Up to USD $25,000. Deadline for applications: June 17, 2019.


April 30, 2019

  • 2019 Annual Faculty of Medicine Grant Writing Workshop.  Grad students, post-docs and faculty members in UofT’s health science community are welcome to register and attend the workshop. Join us to learn more about:
    •   Key Services offered by the Office of the Vice Dean, Research & Innovation
    •   Core Facilities & Services available through the Faculty of Medicine
    Natasha Christie-Holmes, PhD, Research Operations Officer, Faculty of Medicine 
    •   A reviewer’s perspective on grant review panels and grant success
    Professor Brenda Andrews, PhD, Director, Donnelly Centre 
    •   Persuasive grant writing tips and techniques
    Daniel Harney, PhD, Grants & Awards Editor, Faculty of Medicine
    DATE: Tuesday, June 4th from 9am - 12pm
    LOCATION: Medical Sciences Building, Room 3153, 1 King's College Circle, Toronto 
    Free to attend. Register here.
  • Introducing NSERC Alliance grants: Canada’s Research Partnerships Program. Alliance grants encourage greater collaboration in Canada’s R&D system by providing support for projects that include both generators and users of research results and knowledge. Alliance is designed to be more responsive and flexible for our research community and to accommodate a broader range of partners. It also includes incentives for collaborations with small and medium-sized enterprises and multi-sectoral partnerships, and offers an accelerated means for projects to scale and grow. For full details about the Alliance grants and how to apply please visit the new Alliance webpage. Alliance will be launched in a phased approach. On May 21st, Option 1 will be open for applications requesting $150,000 or more annually from NSERC. Option 1 for applications requesting less than $150,000 annually from NSERC, as well as Option 2, will be phased in gradually. Please continue to check the website for the latest information and sign up to the mailing list on the Alliance webpage.
  • Shanghai Jiao Tong University (SJTU) – University of Toronto: Call for Collaborative Research Fund Seed Grants. SJTU and U of T are calling for applications for seed grants to establish joint research collaborations leading to the submission of at least one joint co-authored publication (or equivalent output), at least 2 reciprocal visits for staff and/or students, and targeting a suitable scheme for the submission of a joint application for external research funding. Funding: Up to $15,000 CAD to support U of T-funded researchers; Up to RMB 75,000 to support SJTU-funded researchers. Grants may be renewed for one further period of 12 months subject to performance in fulfilling the objectives of the scheme. Funds may only be spent at SJTU or U of T, and to support joint projects or collaborative activities in any discipline. Deadline for applications: June 22, 2019.
  • Lallemand Microbiome and Probiotics Innovation Grant. The Rosell Institute for Microbiome and Probiotics by Lallemand is launching a funding competition in collaboration with Mitacs to stimulate innovative research in the field of probiotics for human health applications. The goal of this grant is to create a new sustainable partnership with researchers across Canada, to provide training opportunities for students, and to foster breakthrough research. Investigators working on understanding the role of probiotic interventions for different types of health indications, innovative studies on novel indications, animal models and/or novel bacterial isolates are strongly encouraged. Amount: Up to $80,000 over a maximum of three years. Deadline for submissions: July 1, 2019.
  • CIHR: Myalgic Encephalomyelitis (ME) Network Catalyst Grants. The Network Catalyst Grant will support a Network that will generate new knowledge to improve diagnosis and treatment of ME disease in Canada. The network will foster innovative research, build capacity, and be both a catalyst and a forum for discussing ideas, sharing best practices and consulting on challenges. Research will include efforts to define the cause(s) of the condition and test new and existing treatments for ME. Application deadline: May 9, 2019.
  • Lung Cancer Canada: Geoff Ogram Memorial Research Grant. This grant supports advancement in lung cancer research programs that are anywhere in the continuum from basic, high impact discovery to translational work of direct relevance to the clinic and beyond. The goal of the GOMRF program is to provide a mechanism for scientists to study innovations and accelerate the application of new knowledge relating to the early detection of lung cancer and the etiology of lung cancer in different demographics and populations. Applications are encouraged from, but not limited to, the areas of biomedical, clinical, health services, social, and population health research. One $25,000 grant will be awarded. The application form can be found hereDeadline for applications: June 28, 2019.
  • Canadian Blood Services: Blood Efficiency Accelerator Program. The objective of this program is to improve the efficient and appropriate utilization of blood products, while maintaining the safety of the blood system. To achieve this objective, the Program will support innovative research projects that seek new knowledge or accelerate the application of existing knowledge. While all applications aimed at improving the efficient and appropriate utilization of Canadian Blood Services’ blood products are encouraged, the current competition will give priority to projects focused on improving procedures and protocols at Canadian hospitals or at Canadian Blood Services that will result in improved utilization of red blood cells, platelets, and plasma products. Two grants of up to $30,000 will be awarded. Deadline for applications: July 15, 2019.
  • Huntington's Disease Society of America (HDSA): HD Human Biology Project. The Human Biology Project was launched in 2013 with the goal of fostering innovative research in collaboration with HD clinics to better understand the biology of Huntington's disease as it occurs in humans. Applications are welcomed and encouraged from individuals from other areas of research and health care (e.g., biostatisticians, physical therapists, etc). Applications are welcome from all researchers regardless of their position/title. However, preference will be given to young investigators who are not yet independent investigators. Amount: Up to USD $75,000 a year for up to two years. Deadline for Letters of Intent: May 24, 2019.
  • American Academy of Pediatrics (AAP): Research Grant and Young Investigator Award Program. The NRP Steering Committee is interested in the effect of the Neonatal Resuscitation Program on neonatal morbidity and mortality as well as other interventions that may improve the outcome of neonatal resuscitation. What are the best ways to optimize care in the delivery room using NRP? Initiatives can include teaching and evaluating the cognitive, technical and behavioral skills necessary for successful resuscitation of the newborn and retention of skills and knowledge over time. Visit there website to view topics of interest. Upper amount: USD $50,000. Deadline for Notice of Intent: May 3, 2019.
  • Dravet Syndrome Foundation (DSF): Research Grant Program. These grants are intended for established, experienced, independent investigators affiliated with a research or academic institution whose proposed projects investigate hypotheses directly related to Dravet syndrome. 2019 priority areas include: 
    - Transformative research to enhance our understanding of the cellular, molecular, genetic and systems-level mechanisms that lead to Dravet syndrome, facilitating the continued investigation of disease-modifying or preventative strategies 
    - Research that will encourage the development of novel therapies to prevent onset or halt the progression of the Dravet syndrome 
    - Research focused on new, effective treatments for Dravet syndrome and/or its comorbidities 
    Amount: USD $150,000 over two years. Deadline for applications: September 6, 2019.
  • Wellcome Trust: Open Research Fund. This funding supports researchers to develop and test innovative ways of making health research open, accessible and reusable. Proposals that feature collaboration across international borders, and between different sectors and disciplines, are welcome. Search their database of project summaries written by current and past grantholders. These awards are open to individuals or teams of up to six members from anywhere in the world. Amount: Up to GBP £50,000 for up to one year. Deadline for concept paper/proposal: June 17, 2019.
  • Technology, Entertainment, Design (TED): The Audacious Project. Every year, The Audacious Project works with proven change-makers to surface their best, boldest ideas for tackling global problems. No idea is too big or too ambitious - they are looking for ideas that can and must change the world. they believe that the most powerful ideas both inspire and convince. The big ideas that are part of The Audacious Project vary widely - from global health to ocean exploration to social justice to education. They are currently considering all issue areas, and welcome your thoughts on the pressing problems they should be addressing.  Past projects have had an annual operating budget of $1 million USD or more. There are no restrictions on the project funding requests. Ideas that are part of The Audacious Project typically have a timeline of three to five years. Deadline for questionnaires: Continuous.
  • F. Hoffmann-La Roche Ltd./Genentech: Scientific Project Support. Scientific Project Support provides funding for general research, translational research, other research or development projects, and/or other initiatives of research organizations, labs, and academic institutions. Genentech/Roche will consider funding requests in the following disease state: bladder cancer, breast cancer, cervical, colorectal cancer, gastrointestinal cancer, genitourinary cancer, hematologic malignancy, hemophilia, HER2-positive metastatic breast cancer, leukemia, lung cancer, lymphoma, melanoma, metastatic breast cancer, multiple sclerosis, myeloma, non-hodgkins lymphoma, ovarian cancer, pan-tumor, Waldenstrom's Macroglobulinemia, and others. Deadline for proposals: Continuous.


April 17, 2019

  • CIHR Message from the President: Final decision on the Foundation Grant program. CIHR has decided to sunset the Foundation Grant program. CIHR conducted a number of analyses of all completed Foundation Grant competitions, which revealed four main areas of concern: gender, age, institution size, and pillar of research. 
  • University College London - University of Toronto Call for Collaborative Activities Proposals. University College London (UCL) and the University of Toronto (UofT) are contributing matching funds to support collaborative education and research initiatives through a joint call for proposals for the development of collaborative activities. Projects must include research team participants from both UofT and UCL. The UCL collaborator must be from one the following three faculties: UCL Faculty of Life Sciences, UCL Faculty of Arts & Humanities and UCL Faculty of Law. U of T applicants must have a faculty appointment with UofT. 
    Funding: CAD $17,000 to support UofT-funded researchers; £10,000 to support UCL-funded researchers. Duration: One year, beginning May 31, 2019.
    Deadline for applications: April 30, 2019.  
  • Innovation for Defence Excellence and Security (IDEaS): Program Information Session. We invite you to attend an information session for the Innovation for Defence Excellence and Security (IDEaS) program hosted by Eric Fournier, Director General for the IDEaS program at the Department of National Defence (DND). DND is investing $1.6 billion over the next 20 years into the IDEaS program to provide the Canadian Armed Forces (CAF) and Canada’s defense and security communities with unique and innovation solutions to the pressing defence and security challenges of tomorrow. Funding opportunities exist for projects at all technology readiness levels. Visit here for more information about upcoming IDEaS funding opportunities.
    Date: Monday​​​, April 29, 2019 from 9am - 10:30am
    Location: Bahen Centre, Room 1220. Please RSVP by April 22 to engineering.partnerships@utoronto.ca
  • MacArthur Foundation 100&Change Program. The MacArthur Foundation has launched the second round of the 100&Change competition, a competition for a single $100 million grant to fund proposals that promise real and measurable progress in solving a critical problem of our time.100&Change proposals require the articulation of both a problem and its solution.  Competitive proposals will address a significant problem and provide a solution that is impactful, evidence-based, feasible, and durable with demonstrated significant and authentic engagement with affected communities. In response to this opportunity, the Division of the Vice-President, Research & Innovation (VPRI) is inviting interested parties from the U of T community to propose a project or initiative for consideration. Initial proposal summaries of 500 words or less should be submitted to vp.research@utoronto.ca before Tuesday, April 30.  The VPRI and the Division of University Advancement are coordinating efforts to support development of competitive proposals for this program.  Researchers are invited to contact Steven Hermans, Partnership Development Officer, to discuss the program and any potential proposal.
    To learn more about the program, please visit the MacArthur Foundation’s 100&Change website and the resources for applicants.    
  • Genome Canada: Genomic Applications Partnership Program (GAPP) - Round 16. Precision Health Initiative - Rare Diseases: Clinical Implementation Projects. Genome Canada has launched a national initiative for the clinical implementation of precision health, focusing on a rare disease pilot program as a foundational step. Round 16 is now open and Genome Canada is encouraging the submission of projects to the GAPP. For more details, please see here. For more information on the application process, please visit the GAPP homepage, or the UofT funding opportunityDraft EOI is due to RSO and Ontario Genomics on May 21, 2019 at 12 noon.
  • Canadian Foundation for Healthcare Improvement (CFHI): Priority Health Innovation Challenge - Early Innovator Award. The objective of this Challenge is to identify teams and grow promising innovations in two shared health priorities: 1). Improving access to mental health and addictions services; 2). Home and community care. Federal, provincial, and territorial governments have made 12 common indicators focused on measuring pan-Canadian access to these health priorities. Amount: Up to $400,000. Register now. Applications are accepted on a rolling basis until October 20, 2020.
    Early Innovator Award: 
    Upon successful registration, qualifying Teams may submit a video that introduces their team leader, patient and/or family representative, senior officer or director endorsing the work, and demonstrates: a) their current work underway relevant to their chosen indicator(s), and b) their intended aim and anticipated outcomes. Videos must meet the requirements named on page 5 of the official terms. Video deadline: May 10, 2019.
  • Brain Canada Foundation and the Barbara Turnbull Foundation for Spinal Cord Research: 2019 Spinal Turnbull-Tator Award in Spinal Cord Injury and Concussion Research. This award aims to recognize an outstanding publication by a Canadian researcher in the field of spinal cord and brain injury research (including concussion) in the last two years with a $50,000 prize. Applicants will need to demonstrate that their publication includes novel and ground-breaking results that represent a major advancement for the research area and has the potential to generate new hypotheses. The award is open to all active investigators in any phase of their career, graduate students, and postdoctoral fellows conducting research at a Canadian institution. Deadline for applications: May 20, 2019.
  • NIH Various Opportunities. Visit here to see the National Institutes of Health's recently released requests for applications and program announcementsFor more information on NIH application and the submission process, please visit the University's Research Funding Opportunities found here.
  • The Longitude Prize - Antimicrobial Resistance (AMR). The prize aims to support the development of a transformative point-of-care test for antimicrobial resistance (AMR) that is rapid and accurate. This is a £10 million (approximately $17.3M CAD) Challenge Prize competition to support tests that impact treatment decisions to significantly reduce misuse or overuse of antibiotics and conserve antibiotics for future generations. Once the product is being produced at full scale manufacture, the test must be affordable for purchase and use in its intended global market(s), and the time from sample collection to reporting of the result must be less than thirty minutes. There are currently 83 teams competing in the Challenge from 14 countries, including a combination of established private companies, groups from academic institutions and start-ups. Deadline: Applications can be submitted at any time, but they will only be reviewed and assessed every four months: 31 January, 31 May, 30 September. The prize will close if and when a suitable winner is found. The last application deadline, if no winner has been found before then, will be 30 December 2020.

  • Alzheimer's Drug Discovery Foundation: Diagnostics Accelerator - Digital Biomarkers. The Diagnostics Accelerator supports research and development through translational research awards and access to consulting support from industry experts. The current RFP is soliciting projects to develop and validate digital biomarkers for Alzheimer's disease and related dementias. Digital biomarkers are defined as objective, quantifiable physiological and behavioral data that are collected, measured and analyzed by means of digital devices such as portables, wearables, or ambient sensors. Digital biomarkers range from computerized or app-based versions of traditional neurocognitive tests to novel technology platforms that combine multiple complex data sources into a phenotypic signature. Proposals addressing a range of potential clinical uses are of interest, especially technologies for early assessment and those aiding in diagnosis and monitoring treatment response or rate of disease progression. Creative approaches to leverage new and existing software and hardware are encouraged. Deadline for Letters of Intent: June 7, 2019. Three stages of projects will be supported through this call:
    • Exploratory Awards: Amount: Approximately $250,000.
    • Proof-of-Principle Awards: Amount: Approximately $500,000.
    • Validation Awards: Amount: Will be based on the stage and scope of research.
  • amFAR: Mathilde Krim Fellowships in Biomedical Research. The goal of amfAR’s Mathilde Krim Fellowships in Biomedical Research is to: 1). Facilitate the exceptional postdoctoral researcher’s transition to an independent career in HIV/AIDS research within an academic institution or nonprofit organization; 2). Support two years of postdoctoral biomedical research (phase I); 3). Provide the possibility of one additional year of research funding during the first year of an independent research position (phase II). Amount: Up to USD $150,000 over two years. Registration deadline: May 17, 2019; Application deadline: May 22, 2019.
  • Worldwide Cancer Research: Research Grants. Worldwide Cancer Research provides funding for basic and translational research into the prevention, diagnosis or treatment of cancer. They do not prioritize any field of research within this, and welcome research that draws on epidemiological, behavioural and clinical data to provide a starting point for a new avenue of research.  Multidisciplinary or discipline-hopping projects are encouraged where this helps stimulate innovation Amount: Up to £250,000 over 3 years. Deadline for applications: May 3, 2019. 
  • American Heart Association and Amazon Web Services Data Grant Portfolio 4.0 - Artificial Intelligence and Machine Learning Grants. The purpose of this RFA is to test and refine artificial intelligence and machine learning algorithms using learning health care system data and/or multiple longitudinal data sources to improve our understanding of all data related to precision medicine. Data source examples include but are not limited to: images, electronic health records, genetics and omic-related data, community engagement data (including social determinants of health), wearable devices, smart phone and other sensor related technology. Applicants are encouraged to use multiple sources of data, or longitudinal data to continue to refine algorithms. Amount: Up to USD $200,000 over 2 years. Deadline for applications: July 30, 2019.
  • Osteology Foundation: Osteology Researcher Grants. The Foundation offers two types of grants: Advanced Researcher Grants and Young Researcher Grants. The Young Researcher Grants programme supports young researchers in realizing their own research project and fuelling their research career. In both grant programmes clinically relevant questions shall be addressed and the results published open access in international peer-reviewed journals. These grants are intended for research proposals submitted by investigators who want to address questions in the field of oral and maxillofacial tissue regeneration. Amount: Up to CHF 30,000 for one year for Young Researcher Grants; and up to CHF 100,000 for up to two years for Advanced Researcher Grants. Deadline for abstract submissions: June 15, 2019.

April 10, 2019

  • Multiple Myeloma Research Foundation: Research Fellow Awards. The Research Fellow Awards are for researchers who hold a Ph.D., M.D. or equivalent degree at the post-doctorate, clinical fellow or assistant professor levels who are beginning studies in the multiple myeloma field under the supervision of a research mentor or sponsor. Applicants may request up to USD $75,000 for one year. Application deadline: June 24, 2019.
  • NIH Various Opportunities. Visit here to see the National Institutes of Health's recently released requests for applications and program announcementsFor more information on NIH application and the submission process, please visit the University's Research Funding Opportunities found here.
  • Weston Brain Institute: Open Funding Opportunities.
    • Rapid Response Canada. Funding for transformative, novel, high-risk, high-reward translational research projects on neurodegenerative diseases of aging. Amount: Up to $300,000 over 18 months. 
      Parkinson's & Related Diseases: Program INFORMATION WEBINAR: April 3 at 1pm EST. Register hereEXTENDED deadline for LOI's: May 15, 2019 at 2pm EST; Full Proposals deadline: July 16, 2019.
      Alzheimer's & Related Diseases: Deadline for LOI's: April 1, 2019 at 2pm EST; Full Proposals deadline: July 30, 2019.
    • Transformational Research: Canada 2019. Funding for transformative, novel, high-risk, high-reward translational research projects on neurodegenerative diseases of aging. Amount: $200,000 to $1.5M over up to 3 years.
      Deadlines and INFORMATION WEBINARS are the same as the Rapid Response Canada opportunity listed above.
    • Big Ideas: Canada. Projects must have a significant and sustained impact on translational research to accelerate the development of therapeutics for neurodegenerative diseases of aging, and be led by Canadian Researchers. Amount available: $5M - $20M. Applications are accepted on a rolling basis.
    • Early Phase Clinical Trials: Canada. Projects must involve the development of either a therapeutic, a tool, select complementary approaches, or a combination thereof to help accelerate the development of therapeutics for neurodegenerative diseases of aging. Amount: Up to $1,500,000 per project over up to 4 years. Applications are accepted on a rolling basis.
  • Alzheimer's Research UK and the Dementia Consortium: Dementia Consortium Funding. This supports research projects that aim to provide validation of targets for the treatment of dementia or explore the tractability of the target for drug discovery. Promising targets are moved towards the clinic through the successful licence of these projects to industrial partners with the ultimate aim of bringing benefit to patients. Projects are collaborative in nature, with involvement from the consortium members in devising the final project plan. Projects are sought that focus on novel molecular targets in neurodegenerative diseases. Scientists at academic institutions worldwide may apply. Grants are typically worth between £100,000 and £250,000 each over two to three years. Up to £500,000 may be awarded in exceptional cases. Deadline for Expressions of Interest: June 26, 2019.
  • British Heart Foundation: Big Beat Challenge. The Big Beat Challenge is a global competition that will culminate in a single research award of up to £30 million to an international multi-disciplinary team, which has identified and proposed a transformational solution to a significant problem in heart and circulatory disease. It is a challenge to scientists, clinicians, innovators and entrepreneurs to look beyond incremental gains and accelerate research breakthroughs that could transform lives across the globe. Teams must be highly collaborative, mobilising knowledge, skills and resources from multiple disciplines and… more » sectors. Proposals must seek to address a specific area of unmet need with a clear route to patient benefit that is as comprehensible to the general public as it is to patients, healthcare professionals and researchers. Teams must demonstrate that their project would not be possible without the proposed scale of funding. Deadline for Stage 1 applications: June 14, 2019.National Center for Responsible Gambling (NCRG): Grants for Research on Gambling Disorders. 
    • Seed Grants. Applicants may request up to USD $30,000 in direct costs plus 15 percent indirect costs for one year. Deadline for applications: August 1, 2019
    • Large Grants: Large Grants support two-year projects. Applicants may request up to USD $75,000 per year in direct costs and up to 15 percent in indirect costs. Deadline for Letters of Intent: June 3, 2019; Applications deadline: September 3, 2019.
  • NIH Various Opportunities. Visit here to see the National Institutes of Health's recently released requests for applications and program announcementsFor more information on NIH application and the submission process, please visit the University's Research Funding Opportunities found here.

February 5, 2019

  • Mitacs Globalink Research Award - Call for Applications. Up to 200 senior undergraduate and graduate student, as well as postdoctoral fellows from the university can participate in research exchanges through the Globalinks Research Award pathway. Faculty at U of T and an international university from a partner country will jointly supervise research projects. In addition, up to 80 students and postdoctoral fellows from international universities will come to Canada to conduct research at U of T. The funding for this international research mobility will allow students and researchers to build on their professional and academic networks, to refine their research skills in new environments and gain global fluency.
  • Award amount: $6,000 Canadian for 12-24 week long research projects*
    Application deadline: 3 months prior to student arriving at host university
    Eligible participants: undergraduate and graduate Students, and postdoctoral fellows in all disciplines
    Application process: https://learningabroad.utoronto.ca/funding/gra/
    Contact: mahvish.wesley@utoronto.ca
  • The Ontario HIV Treatment Network (OHTN), Endgame Funding Program: Community-Based Research and Evaluation  (CBR&E) Awards. The objective of the CBR & E Funding is to assist communities by supporting the production and discovery of knowledge through community-based research; and the use of evidence to drive programming through participatory program evaluation. Amount: $25,000 - $50,000 for one year. Application deadlines: March 1, June 7, September 6 and December 6, 2019.
    OHTN's Strategic Plan to 2026: HIV Endgame.
  • NIH Various Opportunities. Visit here to see the National Institutes of Health's recently released requests for applications and program announcementsFor more information on NIH application and the submission process, please visit the University's Research Funding Opportunities found here.
  • Alzheimer's Drug Discovery Foundation (ADDF): Funding Opportunities.  The 2019 deadlines for LOIs are January 18; April 12, July 19, or October 11, 2019.
    • Program to Accelerate Clinical Trials (PACT). This RFP funds early-stage clinical trials through phase 2 for novel drug candidates, proof-of-concept trials in patients for repurposed/repositioned drugs, and regulatory studies for IND/CTA preclinical packages and drug manufacturing for later stage trials. Average amount: Up to USD $5M.
    • Neuroimaging and CSF Biomarker Development. This RFP supports the development and validation of neuroimaging and CSF biomarkers to enhance clinical trials for Alzheimer's disease, related dementias, and cognitive aging. Average amount: USD $150,000-$600,000.
    • Prevention Beyond the Pipeline. This RFP supports comparative effectiveness research, prevention clinical trials, and epidemiological studies that probe whether the use or choice of drugs alters the risk for dementia or cognitive decline. Amount: USD $50,000-$100,000 for epidemiological analyses; USD Up to $3 million for clinical trials.
    • Drug Discovery. This RFP supports programs advancing lead molecules to clinical candidate selection or building preclinical evidence in relevant animal models for repurposed/repositioned drugs. Average amount: USD $150,000-$600,000.

  • Muscular Dystrophy Association (MDA): Translational Research. MVP funds projects from proof-of-principle studies through phase 2 trials. For-profit entities are required to contribute funds that match or exceed MDA's contribution. MDA will negotiate return on investment. Projects funded by MVP are milestone-driven projects, with funds released according to the completion of pre-agreed upon sections of the project. MVP will consider funding projects up to USD $1M, depending on the stage of research. MVP is interested in partnering with applicants to accelerate research on projects with strong institutional support, and in general MVP funds should constitute less than 50% of the total project budget. Deadline for Letters of Intent: March 1, 2019; June 1, 2019; and September 1, 2019.